This Q&A describes Amgen Europe HCP preference survey results and wider changes in the way MSLs will work with their HCP peers as we emerge from the pandemic.
This paper describes survey results from Amgen JAPAC Medical Affairs examining the current state in early 2021 of medical engagement amongst healthcare professionals.
Here we explore how some of the top Medical Affairs leaders from Johnson & Johnson think about career leadership development opportunities and challenges.
This MAPS podcast introduces listeners to social listening to gather insights and discusses implementation, value and technologies.
“If you ask patient communities their major concerns, it’s affordable access,” says Alissa Heizler-Mendoza speaking about patient advocacy in Medical Affairs.
MedInfo Teams contribute to the business with clinical expertise, extensive knowledge of the company products and medical literature, insights of customer needs, and a strong understanding of the business.
As Medical Affairs teams we have evolved to become the “natural owners of scientific data across a product’s lifecycle” and are now poised to provide strategic medical direction to our organizations. In this dynamic and conversational webinar, we will review how adaptive connected technology and processes support our mandate to deliver integrated evidence that articulates clear clinical and economic value to improve patient experience and outcomes.
This Webinar will cover:
This session will provide a learning opportunity for our audience by describing:
J&J leaders detail how to think about managing the challenge of broadening the focus of a Medical Affairs career to encompass new and multiple therapeutic areas.
This MAPS podcast identifies potential areas for compliant collaboration by medical science liaisons with key internal Medical Affairs partners